IRODALOM: 1. Abou-Rebyeh H. és mtsai.: Radiation exposure of medical staff during ERCP - measurements of organ doses Digestion 59(Suppl.3):189 2. Agelopoulos C. és mtsai.:…
s303ds2018.01.02.
Irodalom 1. ALEXANDER HR JR, LIBUTTI SK, PINGPUNK JF. ET AL: Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases…
s303ds2018.01.02.
Irodalom: 1. Schmelzer E, Wauthier E, Reid LM: The phenotypes of pluripotent human hepatic progenitors. Stem Cells 24: 1852-1858, 2006. 2. Yovchev MI, Grozdanov…
s303ds2017.12.29.
Irodalom: 1. Androulakis N, Aravantinos G, Syrigos K et al: Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study.…
s303ds2017.12.29.
Irodalom: 1. Guicciardi ME., Gores GJ.: Cholestatic hepatocellular injury: what do we know and how shoud we proceed. J. Hepatology 2006, 42, 297-300. 2.…
s303ds2017.12.29.
Irodalom: 1. ter Borg MJ et al: Patterns of viral decline during PEG-Interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.…
s303ds2017.12.29.
Irodalom: Bioulac-Sage, P. et al.: “Genotype phenotype classification of hepatocellular adenoma.” World J.Gastroenterol. 13.19 (2007): 2649-54. Bioulac-Sage, P. et al.: “Hepatocellular adenoma subtype classification…
s303ds2017.12.29.
Irodalom: Sherman, K., Fleischer R., Laessing K., Murry J., Tauber W., Birnkrant, D: Development of novel agents for the treatment of chronic hepatitis C…
s303ds2017.12.29.
Irodalom: 1. Yonemoto N, Furuse J, Okusaka T, Yamao K, Funakoshi A, Ohkawa S, Boku N, Tanaka K, Nagase M, Saisho H, Sato T.:…
s303ds2017.12.29.
